Hyperkalaemia
1 paper2 findings
Associations
2Finerenone + empagliflozin
upin humans1RR 2.48
1 study
Finerenone + empagliflozin
upin humans1RR 2.48
Finerenone + empagliflozin raises the risk of hyperkalaemia in humans (RR 2.48, 95% CI: 1.22-5.06).
Reviewcompared with empagliflozin alone
Diabetes, obesity & metabolism17 Sep 2026
Finerenone
upin humans1RR 2.03
1 study
Finerenone
upin humans1RR 2.03
Finerenone raises the risk of hyperkalaemia in humans (RR 2.03, 95% CI: 1.82-2.26).
Review
Diabetes, obesity & metabolism17 Sep 2026
Trial sponsors
Company2 trialsPhase 4428 people
Latest
2 in 12 monthsDiabetes, Obesity & Metabolism
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease
Meta-analysis of randomised trialsSGLT2 inhibitors